Many people who successfully lost weight on Ozempic and other GLP-1 agonist drugs are having trouble weaning themselves off the injectables, according to the BBC , because the hunger for food comes roaring back with a vengeance and hence the pounds start creeping up again, hinting that patients are likely to develop life-long dependencies on the substances
doi: 10.1016/j.ajcnut.2025.05.022
The flat monthly pricing model eliminates uncertaintywhether a patient is on 0.5 mg or 2.4 mg weekly, the monthly cost remains the same
Patients in the UK who are interested in accessing retatrutide through a clinical trial can search for active studies via the NIHR 'Be Part of Research' website (bepartofresearch.nihr.ac.uk) or the ClinicalTrials.gov database
Consumer feedback on Wellis food logging experience reveals users enjoy a sense of support throughout the journey, with many praising the personalized nature of the experience
The jump from 2mg to 4mg is where many people report the most noticeable GI effects
